These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 10779418
1. HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha. Casoli C, Vicenzi E, Cimarelli A, Magnani G, Ciancianaini P, Cattaneo E, Dall'Aglio P, Poli G, Bertazzoni U. Blood; 2000 May 01; 95(9):2760-9. PubMed ID: 10779418 [Abstract] [Full Text] [Related]
6. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. Saha K, Bentsman G, Chess L, Volsky DJ. J Virol; 1998 Jan 01; 72(1):876-81. PubMed ID: 9420304 [Abstract] [Full Text] [Related]
9. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS. J Clin Invest; 1998 Jul 01; 102(1):223-31. PubMed ID: 9649576 [Abstract] [Full Text] [Related]
12. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages. Moriuchi H, Moriuchi M, Combadiere C, Murphy PM, Fauci AS. Proc Natl Acad Sci U S A; 1996 Dec 24; 93(26):15341-5. PubMed ID: 8986813 [Abstract] [Full Text] [Related]
13. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients. Bassani S, López M, Toro C, Jiménez V, Sempere JM, Soriano V, Benito JM. Clin Infect Dis; 2007 Jan 01; 44(1):105-10. PubMed ID: 17143825 [Abstract] [Full Text] [Related]
15. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy. De Luca A, Giancola ML, Cingolani A, Ammassari A, Murri R, Antinori A. AIDS Res Hum Retroviruses; 2000 Jun 10; 16(9):835-43. PubMed ID: 10875609 [Abstract] [Full Text] [Related]
16. Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Jansson M, Popovic M, Karlsson A, Cocchi F, Rossi P, Albert J, Wigzell H. Proc Natl Acad Sci U S A; 1996 Dec 24; 93(26):15382-7. PubMed ID: 8986820 [Abstract] [Full Text] [Related]
17. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy. Giovannetti A, Ensoli F, Mazzetta F, De Cristofaro M, Pierdominici M, Muratori DS, Fiorelli V, Aiuti F. Clin Exp Immunol; 1999 Oct 24; 118(1):87-94. PubMed ID: 10540164 [Abstract] [Full Text] [Related]
18. CD8+ T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta. Leith JG, Copeland KF, McKay PJ, Richards CD, Rosenthal KL. AIDS; 1997 Apr 24; 11(5):575-80. PubMed ID: 9108938 [Abstract] [Full Text] [Related]
20. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines. Dolei A, Biolchini A, Serra C, Curreli S, Gomes E, Dianzani F. AIDS; 1998 Jan 22; 12(2):183-90. PubMed ID: 9468367 [Abstract] [Full Text] [Related] Page: [Next] [New Search]